Skip to main content

Research News

 

Clinical courses

  • Nivalis Therapeutics, Inc., a clinical stage pharmaceutical company focused on developing innovative solutions for people with cystic fibrosis (“CF”),  announced the U.S. Food and Drug Administration ("FDA") has granted Orphan Drug Designation to the Company's lead investigational drug, N91115, a novel stabilizer of the cystic fibrosis transmembrane conductance regulator (CFTR) protein.

  • The National Institute of Cholera and Enteric Diseases (NICED), a premier institute under the Indian Council of Medical Research (ICMR), is in talks with the West Bengal government to introduce a cholera vaccine ahead of the peak season as a preventive measure.

  • The Zika virus, spread by a day-biting mosquito and possibly linked to serious birth defects in Brazil, has the potential to spread within the Americas, including parts of the US, researchers have warned. The Zika virus, native to parts of Africa and Asia, has for the first time been introduced into the Americas where it is spreading locally among people who have not travelled abroad.

  • Researchers have discovered a previously unknown cellular defect in patients with Parkinson's disease, and identified a sequence of pathological events that can trigger or accelerate premature death of certain neurons in the brain seen in this disease.

    (adsbygoogle = window.adsbygoogle || []).push({});
Subscribe to Research News